Dihydroberberine 可抑制人类 etHER-a-go-go 相关基因 (HERG) 通道并显着降低 HSP90 表达及其与 HERG 的相互作用，具有抗动脉粥样硬化、抗炎、降血脂和抗肿瘤活性。

Dihydroberberine has anti-atherosclerotic, anti-inflammatory, hypolipidemic and antitumor activities. It inhibits human ether-a-go-go-related gene (hERG) channels and remarkably reduces Hsp90 expression and its interaction with hERG.

483-15-8

C20H19NO4

337.375

DMSO:10 mM
Powder: -20°C for 3 years
In solvent: -80°C for 2 years